Patents by Inventor Heba Ibrahim Abd El-Moaty

Heba Ibrahim Abd El-Moaty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975038
    Abstract: A therapeutic composition including phenolic compounds derived from Opuntia littoralis (OL) includes an extract of Opuntia littoralis and lutein. The Opuntia littoralis extract can be formed by extracting an Opuntia littoralis plant powder with an alcohol to provide an Opuntia littoralis alcohol extract (OLAE) including the phenolic compounds. In an embodiment, the therapeutic composition can be effectively used as an analgesic for the treatment of pain, as an anti-inflammatory, as a treatment for immunological disorders, and/or as a treatment for oxidant conditions.
    Type: Grant
    Filed: July 26, 2023
    Date of Patent: May 7, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Heba Ibrahim Abd El-Moaty, Hairul-Islam Mohamed Ibrahim, Zainab Hussain Almansour, Rabab Salem Hamad
  • Patent number: 11806378
    Abstract: A therapeutic composition including phenolic compounds derived from Opuntia littoralis (OL) includes an extract of Opuntia littoralis and lutein. The Opuntia littoralis extract can be formed by extracting an Opuntia littoralis plant powder with an alcohol to provide an Opuntia littoralis alcohol extract (OLAE) including the phenolic compounds. In an embodiment, the therapeutic composition can be effectively used as an analgesic for the treatment of pain, as an anti-inflammatory, as a treatment for immunological disorders, and/or as a treatment for oxidant conditions.
    Type: Grant
    Filed: March 22, 2023
    Date of Patent: November 7, 2023
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Heba Ibrahim Abd El-Moaty, Hairul-Islam Mohamed Ibrahim, Zainab Hussain Almansour, Rabab Salem Hamad
  • Patent number: 11806363
    Abstract: Euphorbia dendroides silver nanoparticles can have a crystalline structure and an average particle size ranging from about 7 nm to about 13 nm. The Euphorbia dendroides silver nanoparticles may be synthesized by providing a Euphorbia dendroides extract and combining the Euphorbia dendroides extract with silver nitrate. The resultant Euphorbia dendroides silver nanoparticles may be useful in treating a variety of conditions including bacterial infections, diabetes, inflammation, and cancer.
    Type: Grant
    Filed: March 20, 2023
    Date of Patent: November 7, 2023
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Heba Ibrahim Abd El-Moaty, Rasha Abu-Khudir, Mostafa M. H. Khalil, Nadia A. Soliman